Avid Radiopharmaceuticals
Christine Gallagher has a diverse work experience in the pharmaceutical industry. Christine started their career at sanofi-aventis as an Analytical Chemist, Contract in 2002 and worked there until 2005. Christine then moved on to become a Scientist I from 2005 to 2008, and later a Scientist II from 2009 to 2011 at the same company. In 2011, Christine joined Avid Radiopharmaceuticals as a QC Chemist II until 2013 when they became a QC Manager. Christine then held the position of Sr QA Associate from 2014 to 2018, followed by the role of Quality Assurance Manager from 2018 to 2022. Currently, they hold the position of Associate Director Quality Engineering at Avid Radiopharmaceuticals.
Christine Gallagher earned a Bachelor's degree in Biology from Millersville University of Pennsylvania, between 1997 and 2001.
This person is not in any teams
Avid Radiopharmaceuticals
1 followers
At Avid, a wholly owned subsidiary of Eli Lilly and Company, our mission is to develop new molecular imaging agents capable of changing the medical management of significant chronic human diseases. We have assembled an outstanding management team with extensive imaging and CNS development experience to help make pre-symptomatic disease detection a reality. Avid's pipeline of imaging compounds has the potential to dramatically alter the clinical course of challenging conditions such as Alzheimer's disease, Dementia with Lewy Bodies, Parkinson's disease and Diabetes Mellitus. This may be possible because our molecular imaging compounds may be able to detect the first stages of pathological change; allowing early treatment and management of people at risk - perhaps before before symptoms of disease can develop.